Stifel Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.8M | Sell |
|
|||||
|
2025
Q2 | $16.3M | Sell |
|
|||||
|
2025
Q1 | $13.8M | Sell |
|
|||||
|
2024
Q4 | $13.9M | Sell |
|
|||||
|
2024
Q3 | $14M | Sell |
|
|||||
|
2024
Q2 | $11.4M | Sell |
|
|||||
|
2024
Q1 | $9.37M | Sell |
|
|||||
|
2023
Q4 | $11M | Buy |
|
|||||
|
2023
Q3 | $13.1M | Sell |
|
|||||
|
2023
Q2 | $13M | Buy |
|
|||||
|
2023
Q1 | $15.4M | Hold |
|
|||||
|
2022
Q4 | $21.2M | Sell |
|
|||||
|
2022
Q3 | $23.3M | Sell |
|
|||||
|
2022
Q2 | $19.6M | Sell |
|
|||||
|
2022
Q1 | $30.1M | Buy |
|
|||||
|
2021
Q4 | $25.6M | Sell |
|
|||||
|
2021
Q3 | $26.6M | Hold |
|
|||||
|
2021
Q2 | $29.3M | Hold |
|
|||||
|
2021
Q1 | $18.8M | Sell |
|
|||||
|
2020
Q4 | $15.2M | Hold |
|
|||||
|
2020
Q3 | $7.01M | Hold |
|
|||||
|
2020
Q2 | $9.73M | Sell |
|
|||||
|
2020
Q1 | $4.18M | Buy |
|